本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atrium Therapeutics

13.23
+0.13000.99%
盘后13.230.00000.00%19:16 EDT
成交量:41.08万
成交额:538.56万
市值:2.05亿
市盈率:-4.15
高:13.28
开:13.00
低:12.90
收:13.10
52周最高:16.77
52周最低:11.95
股本:1,551.50万
流通股本:1,113.53万
量比:0.63
换手率:3.69%
股息:- -
股息率:- -
每股收益(TTM):-3.1910
每股收益(LYR):-3.1905
净资产收益率:-43.98%
总资产收益率:-399.25%
市净率:-3.27
市盈率(LYR):-4.15

数据加载中...

2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report